Trichotillomania Clinical Trial
Official title:
Treatment Development Study of the COMB Model of Trichotillomania
Verified date | April 2015 |
Source | American University |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
This pilot study is being conducted in order to help make the case for later, more systematic research on the effectiveness of the Comprehensive Behavioral (COMB) model of treating trichotillomania (compulsive hair pulling). The goals are to standardize COMB treatment techniques in the form of a clear written manual for therapists; determine whether therapists can use these guidelines in a consistent manner in making treatment decisions; develop and test the reliability of measures of how well therapists are conducting the treatment; and collect preliminary data on the acceptability of the treatment to patients.
Status | Completed |
Enrollment | 16 |
Est. completion date | |
Est. primary completion date | January 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - 18 years or older - Primary Diagnostic and Statistical Manual, Fifth Edition (DSM-5) diagnosis of Trichotillomania (TTM) Exclusion Criteria: - Current suicidality or severe depression - Current psychosis - Current alcohol or substance abuse - Concurrent psychotherapy for TTM - Psychotropic meds (for any disorder) that have not been stable for >4 weeks |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | American University | Washington | District of Columbia |
Lead Sponsor | Collaborator |
---|---|
American University | Trichotillomania Learning Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Massachusetts General Hospital Hairpulling Scale (MGH-HS) | Improvement in hair pulling symptoms | 12 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01445444 -
Habit Reversal Training for Children and Adolescents With Trichotillomania
|
N/A | |
Completed |
NCT04559750 -
Internet CBT for Trichotillomania and Skin Picking Disorder
|
N/A | |
Completed |
NCT01638975 -
Response Inhibition Training for Individuals With Trichotillomania
|
N/A | |
Completed |
NCT00993265 -
N-Acetylcysteine for Pediatric Trichotillomania
|
Phase 2 | |
Completed |
NCT00917098 -
Examining Behavior Therapy for Trichotillomania in Children and Adolescents
|
N/A | |
Recruiting |
NCT00552266 -
Methylphenidate in ADHD With Trichotillomania
|
Phase 4 | |
Completed |
NCT03530800 -
Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors
|
Phase 2/Phase 3 | |
Completed |
NCT01984333 -
Online Response Inhibition Training for Trichotillomania
|
N/A | |
Completed |
NCT00740909 -
Cognitive Behavioral Therapy for Trichotillomania
|
Phase 1/Phase 2 | |
Recruiting |
NCT05003401 -
Leveraging Technological Advancements to Improve the Treatment of Trichotillomania
|
N/A | |
Completed |
NCT01875445 -
Inositol in Trichotillomania
|
Phase 2 | |
Completed |
NCT03486041 -
Comprehensive Behavioral (ComB) Model of Treatment for Trichotillomania
|
N/A | |
Completed |
NCT02473913 -
Milk Thistle in Trichotillomania in Children and Adults
|
Phase 2 | |
Completed |
NCT00872742 -
Testing a New Therapy for Trichotillomania
|
Phase 2 | |
Completed |
NCT00182507 -
Olanzapine in the Treatment of Hair Pulling (Trichotillomania)
|
Phase 4 | |
Completed |
NCT00947154 -
Trial of Aripiprazole in Trichotillomania
|
N/A | |
Completed |
NCT00354770 -
N-Acetyl Cysteine in Trichotillomania
|
Phase 2 | |
Completed |
NCT00004550 -
Evaluation and Follow-up of Individuals With Obsessive-Compulsive Disorder and Related Conditions
|
N/A | |
Active, not recruiting |
NCT01075672 -
Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals
|
N/A | |
Completed |
NCT01968343 -
Trichotillomania: Group Cognitive-Behavioral Therapy
|
Phase 2 |